Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Clinical trial NCT01254279 · COMPLETED

Trial details

NCT number: NCT01254279
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer Metastatic

Start date: 2010-12-01
Primary completion: 2014-12-01
Enrollment: 984

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.